# Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer.

> **NCT00160043** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 112 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** SH T00268C
- **DRUG:** PTK787/ ZK 222584

## Key facts

- **NCT ID:** NCT00160043
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2007-08
- **Final completion:** 2008-11
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2014-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00160043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00160043, "Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer.". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00160043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*